Active substance
Leucovorin
- US FDA 61
- Health Canada 9
- US price lines 4
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| LEUCOVORIN CALCIUM | EQ 50MG BASE/VIAL | injectable · injection | HIKMA PHARMS | Prescription | 14 Sep 1987 |
| LEUCOVORIN CALCIUM | EQ 5MG BASE | tablet · oral | BARR | Prescription | 24 Sep 1987 |
| LEUCOVORIN CALCIUM | EQ 25MG BASE | tablet · oral | BARR | Prescription | 24 Sep 1987 |
| LEUCOVORIN CALCIUM | EQ 100MG BASE/VIAL | injectable · injection | HIKMA PHARMS | Prescription | 28 Mar 1988 |
| LEUCOVORIN CALCIUM | EQ 5MG BASE | tablet · oral | HIKMA PHARMS | Prescription | 22 Feb 1993 |
| LEUCOVORIN CALCIUM | EQ 10MG BASE | tablet · oral | HIKMA PHARMS | Prescription | 22 Feb 1993 |
| LEUCOVORIN CALCIUM | EQ 15MG BASE | tablet · oral | HIKMA PHARMS | Prescription | 22 Feb 1993 |
| LEUCOVORIN CALCIUM | EQ 25MG BASE | tablet · oral | HIKMA PHARMS | Prescription | 22 Feb 1993 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 200MG BASE/VIAL | injectable · injection | HIKMA PHARMS | Prescription | 23 May 1995 |
| LEUCOVORIN CALCIUM | EQ 5MG BASE; EQ 25MG BASE; EQ 10MG BASE; EQ 15MG BASE | tablet · oral | EPIC PHARMA LLC | Prescription | 28 Aug 1997 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 200MG BASE/VIAL | injectable · injection | FRESENIUS KABI USA | Prescription | 26 Feb 1999 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 500MG BASE/VIAL | injectable · injection | FRESENIUS KABI USA | Prescription | 26 Feb 1999 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 350MG BASE/VIAL | injectable · injection | HIKMA PHARMS | Prescription | 20 Apr 2000 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 50MG BASE/VIAL; EQ 100MG BASE/VIAL; EQ 200MG BASE/VIAL | injectable · injection | SAGENT PHARMS | Prescription | 6 Sep 2012 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 350MG BASE/VIAL | injectable · injection | SAGENT PHARMS | Prescription | 6 Sep 2012 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 100MG BASE/VIAL; EQ 200MG BASE/VIAL; EQ 350MG BASE/VIAL | injectable · injection | MYLAN LABS LTD | Prescription | 19 May 2017 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE | EQ 500MG BASE/VIAL | injectable · injection | SAGENT PHARMS INC | Prescription | 26 Oct 2017 |
| LEUCOVORIN CALCIUM | EQ 100MG BASE/10ML (EQ 10MG BASE/ML) | solution · intramuscular, intravenous | FRESENIUS KABI USA | Prescription | 14 Mar 2018 |
| LEUCOVORIN CALCIUM | EQ 500MG BASE/50ML (EQ 10MG BASE/ML) | solution · intramuscular, intravenous | FRESENIUS KABI USA | Prescription | 27 Jul 2018 |
| LEUCOVORIN CALCIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 15MG BASE; EQ 25MG BASE | tablet · oral | INGENUS PHARMS LLC | Prescription | 30 Jul 2020 |
| LEUCOVORIN CALCIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 15MG BASE; EQ 25MG BASE | tablet · oral | LEADING | Prescription | 22 Oct 2020 |
| LEUCOVORIN CALCIUM | EQ 50MG BASE/VIAL; EQ 100MG BASE/VIAL; EQ 200MG BASE/VIAL; EQ 500MG BASE/VIAL; EQ 350MG BASE/VIAL | injectable · injection | HAINAN POLY | Prescription | 10 Jul 2023 |
| LEUCOVORIN CALCIUM | EQ 50MG BASE/VIAL; EQ 100MG BASE/VIAL; EQ 200MG BASE/VIAL; EQ 350MG BASE/VIAL; EQ 500MG BASE/VIAL | injectable · injection | MEITHEAL | Prescription | 19 Jul 2023 |
| LEUCOVORIN CALCIUM | EQ 350MG BASE/VIAL | injectable · injection | GLAND | Prescription | 12 Nov 2025 |
| VYKOURA | EQ 50MG BASE/5ML (EQ 10MG BASE/ML); EQ 350MG BASE/35ML (EQ 10MG BASE/ML); EQ 500MG BASE/50ML (EQ 10MG BASE/ML) | solution · intramuscular, intravenous | AVYXA HOLDINGS | Prescription | 3 Feb 2026 |
36 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JAMP LEUCOVORIN | 02548208 | 5 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| LEDERLE LEUCOVORIN | 02170493 | 5 MG | TABLET · ORAL | PFIZER CANADA ULC |
| LEUCOVORIN CALCIUM INJECTION | 02087316 | 10 MG / ML | SOLUTION · INTRAVENOUS; INTRAMUSCULAR | TEVA CANADA LIMITED |
| LEUCOVORIN CALCIUM INJECTION | 02480042 | 10 MG / ML | SOLUTION · INTRAMUSCULAR; INTRAVENOUS | GENERIC MEDICAL PARTNERS INC |
| LEUCOVORIN CALCIUM INJECTION | 02496925 | 1000 MG / 100 ML | SOLUTION · INTRAVENOUS | GENERIC MEDICAL PARTNERS INC |
| LEUCOVORIN CALCIUM INJECTION USP | 02182998 | 10 MG / ML | SOLUTION · INTRAVENOUS | PFIZER CANADA ULC |
| LEUCOVORIN CALCIUM INJECTION USP | 02183005 | 10 MG / ML | SOLUTION · INTRAMUSCULAR; INTRAVENOUS | PFIZER CANADA ULC |
| MINT-LEUCOVORIN | 02496828 | 5 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| RIVA LEUCOVORIN | 02493357 | 5 MG | TABLET · ORAL | LABORATOIRE RIVA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | LEUCOVORIN CALCIUM 10 MG TAB | $2.07783 | per EA | 23 Sep 2026 |
| US NADAC | LEUCOVORIN CALCIUM 15 MG TAB | $1.58667 | per EA | 23 Sep 2026 |
| US NADAC | LEUCOVORIN CALCIUM 25 MG TAB | $1.60475 | per EA | 23 Sep 2026 |
| US NADAC | LEUCOVORIN CALCIUM 5 MG TAB | $0.33003 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.